 Gregory Austin
Concepts (271)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Proton Pump Inhibitors | 7 | 2018 | 109 | 2.700 |
Why?
| | Adenoma | 9 | 2022 | 218 | 2.510 |
Why?
| | Gastric Bypass | 6 | 2017 | 126 | 2.370 |
Why?
| | Colonoscopy | 10 | 2022 | 261 | 2.290 |
Why?
| | Colorectal Neoplasms | 10 | 2022 | 849 | 1.940 |
Why?
| | Obesity, Morbid | 6 | 2017 | 288 | 1.730 |
Why?
| | Energy Intake | 6 | 2015 | 508 | 1.390 |
Why?
| | Intestines | 3 | 2017 | 358 | 1.100 |
Why?
| | Weight Loss | 5 | 2017 | 838 | 1.020 |
Why?
| | Gastric Acid | 3 | 2015 | 14 | 0.950 |
Why?
| | Gastroesophageal Reflux | 3 | 2015 | 236 | 0.930 |
Why?
| | Laparoscopy | 5 | 2017 | 477 | 0.870 |
Why?
| | Colonic Polyps | 2 | 2021 | 85 | 0.760 |
Why?
| | RNA, Ribosomal, 16S | 3 | 2017 | 559 | 0.760 |
Why?
| | Postoperative Care | 2 | 2015 | 290 | 0.750 |
Why?
| | Medicaid | 2 | 2016 | 466 | 0.670 |
Why?
| | Body Mass Index | 7 | 2018 | 2439 | 0.660 |
Why?
| | Anemia, Iron-Deficiency | 1 | 2021 | 62 | 0.650 |
Why?
| | Diet | 5 | 2015 | 1285 | 0.640 |
Why?
| | Education | 1 | 2020 | 104 | 0.610 |
Why?
| | Microbiota | 4 | 2017 | 781 | 0.570 |
Why?
| | Research Personnel | 1 | 2020 | 186 | 0.540 |
Why?
| | Mentors | 1 | 2020 | 219 | 0.530 |
Why?
| | Bariatric Surgery | 1 | 2021 | 242 | 0.530 |
Why?
| | Diet, Carbohydrate-Restricted | 2 | 2009 | 37 | 0.530 |
Why?
| | Triage | 1 | 2020 | 249 | 0.510 |
Why?
| | Obesity | 5 | 2015 | 3085 | 0.510 |
Why?
| | Mentoring | 1 | 2020 | 166 | 0.500 |
Why?
| | Nutrition Surveys | 5 | 2018 | 282 | 0.490 |
Why?
| | Early Detection of Cancer | 5 | 2022 | 469 | 0.480 |
Why?
| | Middle Aged | 32 | 2020 | 36021 | 0.450 |
Why?
| | Gastrectomy | 1 | 2017 | 161 | 0.440 |
Why?
| | Weight Gain | 2 | 2015 | 564 | 0.430 |
Why?
| | Cardiovascular Diseases | 2 | 2018 | 2182 | 0.400 |
Why?
| | Antidepressive Agents | 1 | 2015 | 248 | 0.400 |
Why?
| | Preoperative Care | 1 | 2016 | 382 | 0.390 |
Why?
| | Dietary Sucrose | 1 | 2013 | 49 | 0.390 |
Why?
| | Midazolam | 1 | 2013 | 72 | 0.380 |
Why?
| | Insurance Coverage | 1 | 2015 | 243 | 0.380 |
Why?
| | Insulin Resistance | 2 | 2018 | 1243 | 0.360 |
Why?
| | Polyethylene Glycols | 1 | 2017 | 655 | 0.360 |
Why?
| | Fentanyl | 1 | 2013 | 127 | 0.350 |
Why?
| | Inflammatory Bowel Diseases | 2 | 2007 | 365 | 0.350 |
Why?
| | Female | 36 | 2020 | 78605 | 0.350 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2018 | 656 | 0.350 |
Why?
| | Male | 34 | 2020 | 72628 | 0.350 |
Why?
| | Humans | 48 | 2022 | 145305 | 0.340 |
Why?
| | Motor Activity | 2 | 2015 | 725 | 0.340 |
Why?
| | Dietary Fats | 1 | 2013 | 315 | 0.340 |
Why?
| | Adult | 26 | 2020 | 40627 | 0.330 |
Why?
| | Education, Medical | 2 | 2013 | 276 | 0.320 |
Why?
| | Medicare | 1 | 2016 | 890 | 0.320 |
Why?
| | Length of Stay | 2 | 2015 | 1342 | 0.300 |
Why?
| | Patient Readmission | 1 | 2015 | 760 | 0.290 |
Why?
| | Irritable Bowel Syndrome | 1 | 2009 | 29 | 0.290 |
Why?
| | Ethanol | 1 | 2013 | 627 | 0.280 |
Why?
| | Predictive Value of Tests | 6 | 2020 | 2118 | 0.280 |
Why?
| | Aged | 15 | 2020 | 26001 | 0.280 |
Why?
| | Intestinal Mucosa | 4 | 2018 | 677 | 0.270 |
Why?
| | Diarrhea | 1 | 2009 | 194 | 0.270 |
Why?
| | Health Services Research | 1 | 2010 | 396 | 0.260 |
Why?
| | Serologic Tests | 1 | 2007 | 53 | 0.250 |
Why?
| | Dysbiosis | 3 | 2017 | 187 | 0.250 |
Why?
| | Inflammation | 1 | 2018 | 2881 | 0.250 |
Why?
| | Fruit | 1 | 2007 | 152 | 0.240 |
Why?
| | Meat | 1 | 2007 | 93 | 0.240 |
Why?
| | Lymphocyte Activation | 4 | 2017 | 1127 | 0.240 |
Why?
| | Family | 1 | 2011 | 682 | 0.240 |
Why?
| | Retrospective Studies | 12 | 2017 | 17149 | 0.230 |
Why?
| | Fellowships and Scholarships | 1 | 2010 | 357 | 0.230 |
Why?
| | Colon | 3 | 2018 | 305 | 0.230 |
Why?
| | Alcohol Drinking | 2 | 2013 | 826 | 0.210 |
Why?
| | HIV Infections | 5 | 2018 | 3158 | 0.210 |
Why?
| | Cholangiopancreatography, Endoscopic Retrograde | 4 | 2016 | 220 | 0.200 |
Why?
| | Practice Patterns, Physicians' | 1 | 2012 | 1358 | 0.200 |
Why?
| | Exercise | 1 | 2015 | 2206 | 0.200 |
Why?
| | Time Factors | 6 | 2017 | 7186 | 0.190 |
Why?
| | Young Adult | 9 | 2020 | 14163 | 0.190 |
Why?
| | Aging | 1 | 2013 | 1968 | 0.180 |
Why?
| | Mass Screening | 1 | 2011 | 1357 | 0.180 |
Why?
| | Liver Transplantation | 2 | 2011 | 827 | 0.170 |
Why?
| | Gastric Acidity Determination | 2 | 2014 | 6 | 0.170 |
Why?
| | United States | 6 | 2018 | 16051 | 0.170 |
Why?
| | Cohort Studies | 3 | 2017 | 5982 | 0.170 |
Why?
| | Risk Factors | 8 | 2020 | 10816 | 0.170 |
Why?
| | Age Factors | 2 | 2020 | 3339 | 0.160 |
Why?
| | HIV-1 | 3 | 2017 | 897 | 0.160 |
Why?
| | Adenomatous Polyps | 1 | 2020 | 9 | 0.160 |
Why?
| | Cross-Sectional Studies | 5 | 2018 | 5883 | 0.160 |
Why?
| | Smoking | 1 | 2007 | 1472 | 0.150 |
Why?
| | Blood Component Transfusion | 2 | 2011 | 103 | 0.150 |
Why?
| | Biomarkers | 4 | 2018 | 4284 | 0.140 |
Why?
| | Treatment Outcome | 6 | 2017 | 11731 | 0.140 |
Why?
| | Case-Control Studies | 5 | 2016 | 3613 | 0.140 |
Why?
| | Iron | 1 | 2021 | 359 | 0.140 |
Why?
| | Practice Guidelines as Topic | 2 | 2020 | 1568 | 0.130 |
Why?
| | Colorado | 4 | 2020 | 4579 | 0.130 |
Why?
| | Interferon Type I | 1 | 2018 | 145 | 0.130 |
Why?
| | Leukocytes, Mononuclear | 2 | 2018 | 573 | 0.130 |
Why?
| | Follow-Up Studies | 4 | 2014 | 5431 | 0.130 |
Why?
| | Acute Lung Injury | 2 | 2011 | 303 | 0.130 |
Why?
| | Narrow Band Imaging | 2 | 2016 | 14 | 0.130 |
Why?
| | Sex Factors | 2 | 2013 | 2115 | 0.130 |
Why?
| | Immunity, Mucosal | 1 | 2017 | 98 | 0.120 |
Why?
| | Biliary Tract Diseases | 1 | 2016 | 33 | 0.120 |
Why?
| | Solutions | 1 | 2017 | 167 | 0.120 |
Why?
| | Bacterial Translocation | 1 | 2017 | 52 | 0.120 |
Why?
| | Guideline Adherence | 1 | 2021 | 589 | 0.120 |
Why?
| | Genitalia | 1 | 2016 | 34 | 0.120 |
Why?
| | Quality of Life | 1 | 2009 | 3197 | 0.120 |
Why?
| | Pancreatic Diseases | 1 | 2016 | 66 | 0.120 |
Why?
| | Butyrates | 1 | 2017 | 67 | 0.120 |
Why?
| | Polyethylene | 1 | 2016 | 17 | 0.120 |
Why?
| | Immunologic Factors | 1 | 2018 | 258 | 0.120 |
Why?
| | Esophageal Motility Disorders | 1 | 2016 | 29 | 0.120 |
Why?
| | Esophagogastric Junction | 1 | 2016 | 56 | 0.120 |
Why?
| | Hernia, Hiatal | 1 | 2016 | 41 | 0.120 |
Why?
| | Program Evaluation | 1 | 2020 | 949 | 0.110 |
Why?
| | Surveys and Questionnaires | 3 | 2020 | 6079 | 0.110 |
Why?
| | Endosonography | 2 | 2016 | 158 | 0.110 |
Why?
| | Pancreatic Ducts | 1 | 2016 | 81 | 0.110 |
Why?
| | Pancreatitis, Chronic | 1 | 2016 | 63 | 0.110 |
Why?
| | Aged, 80 and over | 3 | 2018 | 8295 | 0.110 |
Why?
| | Rectum | 1 | 2016 | 180 | 0.110 |
Why?
| | Emtricitabine | 1 | 2016 | 205 | 0.110 |
Why?
| | Sensitivity and Specificity | 1 | 2020 | 1992 | 0.110 |
Why?
| | Verrucomicrobia | 1 | 2014 | 5 | 0.110 |
Why?
| | Proteobacteria | 1 | 2014 | 16 | 0.110 |
Why?
| | Bacteroidetes | 1 | 2014 | 21 | 0.110 |
Why?
| | Cholangitis, Sclerosing | 2 | 2016 | 60 | 0.110 |
Why?
| | Tenofovir | 1 | 2016 | 295 | 0.110 |
Why?
| | Mucous Membrane | 1 | 2015 | 128 | 0.100 |
Why?
| | Dementia | 1 | 2018 | 304 | 0.100 |
Why?
| | Esophagus | 1 | 2016 | 261 | 0.100 |
Why?
| | Multivariate Analysis | 2 | 2007 | 1540 | 0.100 |
Why?
| | Diet Records | 1 | 2013 | 85 | 0.100 |
Why?
| | Polyps | 1 | 2013 | 14 | 0.100 |
Why?
| | Endotoxemia | 1 | 2014 | 87 | 0.100 |
Why?
| | Anesthetics, Intravenous | 1 | 2013 | 69 | 0.100 |
Why?
| | Immunity | 1 | 2014 | 139 | 0.100 |
Why?
| | Dietary Carbohydrates | 1 | 2013 | 151 | 0.090 |
Why?
| | Neoplasm Staging | 1 | 2016 | 1470 | 0.090 |
Why?
| | Prevalence | 2 | 2011 | 2838 | 0.090 |
Why?
| | Veterans | 1 | 2004 | 1615 | 0.090 |
Why?
| | Stents | 1 | 2016 | 557 | 0.090 |
Why?
| | Cluster Analysis | 2 | 2017 | 521 | 0.080 |
Why?
| | Receptors, Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2011 | 16 | 0.080 |
Why?
| | Ambulatory Care | 1 | 2016 | 603 | 0.080 |
Why?
| | Bile Duct Neoplasms | 1 | 2012 | 130 | 0.080 |
Why?
| | C-Reactive Protein | 1 | 2013 | 420 | 0.080 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2020 | 1420 | 0.080 |
Why?
| | Gastrointestinal Microbiome | 2 | 2017 | 772 | 0.080 |
Why?
| | Kidney | 1 | 2018 | 1499 | 0.080 |
Why?
| | Gastroenterology | 1 | 2013 | 190 | 0.080 |
Why?
| | Fatty Acids | 1 | 2013 | 452 | 0.080 |
Why?
| | Bacteria | 1 | 2017 | 891 | 0.080 |
Why?
| | Prospective Studies | 4 | 2016 | 8011 | 0.080 |
Why?
| | Cost-Benefit Analysis | 1 | 2012 | 639 | 0.080 |
Why?
| | Feeding Behavior | 1 | 2015 | 692 | 0.080 |
Why?
| | Pancreatitis | 1 | 2010 | 145 | 0.080 |
Why?
| | Colitis, Ulcerative | 1 | 2011 | 148 | 0.070 |
Why?
| | Reference Values | 1 | 2011 | 798 | 0.070 |
Why?
| | Adolescent | 4 | 2018 | 22507 | 0.070 |
Why?
| | Health Care Costs | 1 | 2012 | 427 | 0.070 |
Why?
| | Gastrointestinal Hemorrhage | 1 | 2010 | 137 | 0.070 |
Why?
| | Anti-HIV Agents | 1 | 2016 | 890 | 0.070 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2015 | 918 | 0.070 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2015 | 1130 | 0.070 |
Why?
| | Erythrocyte Transfusion | 1 | 2011 | 231 | 0.070 |
Why?
| | Regression Analysis | 1 | 2011 | 1003 | 0.070 |
Why?
| | Pancreatic Neoplasms | 2 | 2016 | 928 | 0.070 |
Why?
| | Patient Discharge | 1 | 2015 | 987 | 0.070 |
Why?
| | Cross Infection | 1 | 2011 | 263 | 0.070 |
Why?
| | Linoleic Acids, Conjugated | 1 | 2007 | 7 | 0.060 |
Why?
| | Crohn Disease | 1 | 2011 | 260 | 0.060 |
Why?
| | North Carolina | 1 | 2007 | 128 | 0.060 |
Why?
| | Antibodies, Fungal | 1 | 2006 | 11 | 0.060 |
Why?
| | Porins | 1 | 2006 | 18 | 0.060 |
Why?
| | Antibodies, Antineutrophil Cytoplasmic | 1 | 2006 | 33 | 0.060 |
Why?
| | Prognosis | 3 | 2011 | 4310 | 0.060 |
Why?
| | Antibodies, Bacterial | 1 | 2006 | 148 | 0.060 |
Why?
| | Immunity, Innate | 1 | 2011 | 846 | 0.050 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2006 | 563 | 0.050 |
Why?
| | Immunoglobulin A | 1 | 2006 | 214 | 0.050 |
Why?
| | Life Style | 1 | 2007 | 483 | 0.050 |
Why?
| | Intensive Care Units | 1 | 2010 | 916 | 0.050 |
Why?
| | Liver Failure | 1 | 2004 | 83 | 0.050 |
Why?
| | Body Composition | 1 | 2007 | 708 | 0.050 |
Why?
| | Biopsy | 2 | 2018 | 1079 | 0.050 |
Why?
| | External Fixators | 2 | 1999 | 21 | 0.050 |
Why?
| | Viral Load | 2 | 2015 | 527 | 0.040 |
Why?
| | Saccharomyces cerevisiae Proteins | 1 | 2006 | 419 | 0.040 |
Why?
| | Diagnosis, Differential | 1 | 2006 | 1500 | 0.040 |
Why?
| | Immunoglobulin G | 1 | 2006 | 893 | 0.040 |
Why?
| | Hepatitis C | 1 | 2004 | 254 | 0.040 |
Why?
| | Incidence | 1 | 2007 | 2892 | 0.040 |
Why?
| | Range of Motion, Articular | 2 | 1999 | 424 | 0.040 |
Why?
| | Survival Rate | 1 | 2004 | 2100 | 0.040 |
Why?
| | Colles' Fracture | 1 | 1999 | 2 | 0.040 |
Why?
| | Fracture Healing | 1 | 1999 | 91 | 0.030 |
Why?
| | Wrist Joint | 1 | 1999 | 71 | 0.030 |
Why?
| | Radius Fractures | 1 | 1999 | 69 | 0.030 |
Why?
| | Fracture Fixation | 1 | 1999 | 79 | 0.030 |
Why?
| | Health Literacy | 1 | 2020 | 184 | 0.030 |
Why?
| | Choledochal Cyst | 1 | 2016 | 17 | 0.030 |
Why?
| | DNA, Ribosomal | 1 | 2017 | 94 | 0.030 |
Why?
| | Natural Orifice Endoscopic Surgery | 1 | 2016 | 34 | 0.030 |
Why?
| | Biliary Tract Neoplasms | 1 | 2016 | 31 | 0.030 |
Why?
| | Risk Assessment | 2 | 2020 | 3686 | 0.030 |
Why?
| | Manometry | 1 | 2016 | 97 | 0.030 |
Why?
| | Constriction, Pathologic | 1 | 2016 | 248 | 0.030 |
Why?
| | Spermatozoa | 1 | 2016 | 109 | 0.030 |
Why?
| | Video Recording | 1 | 2016 | 214 | 0.030 |
Why?
| | DNA, Bacterial | 1 | 2017 | 342 | 0.030 |
Why?
| | Ruminococcus | 1 | 2015 | 8 | 0.030 |
Why?
| | Endoscopy, Digestive System | 1 | 2016 | 141 | 0.030 |
Why?
| | Prevotella | 1 | 2015 | 26 | 0.030 |
Why?
| | Antigens, CD1 | 1 | 2015 | 60 | 0.030 |
Why?
| | Single-Blind Method | 1 | 2016 | 319 | 0.030 |
Why?
| | Patient Education as Topic | 1 | 2020 | 782 | 0.030 |
Why?
| | Colitis | 1 | 2017 | 280 | 0.030 |
Why?
| | Immunoglobulins | 1 | 2015 | 160 | 0.030 |
Why?
| | CD40 Antigens | 1 | 2015 | 90 | 0.030 |
Why?
| | Electronic Health Records | 1 | 2022 | 1177 | 0.030 |
Why?
| | Sequence Analysis, DNA | 1 | 2017 | 824 | 0.030 |
Why?
| | Flow Cytometry | 1 | 2017 | 1173 | 0.030 |
Why?
| | Feces | 1 | 2017 | 514 | 0.020 |
Why?
| | CD4 Lymphocyte Count | 1 | 2014 | 278 | 0.020 |
Why?
| | Cell Lineage | 1 | 2015 | 378 | 0.020 |
Why?
| | Glycoproteins | 1 | 2015 | 355 | 0.020 |
Why?
| | Histocytochemistry | 1 | 2013 | 79 | 0.020 |
Why?
| | Carcinoma, Pancreatic Ductal | 1 | 2016 | 292 | 0.020 |
Why?
| | Phylogeny | 1 | 2017 | 1020 | 0.020 |
Why?
| | Membrane Glycoproteins | 1 | 2015 | 501 | 0.020 |
Why?
| | Antigens, CD | 1 | 2015 | 555 | 0.020 |
Why?
| | Pilot Projects | 1 | 2017 | 1894 | 0.020 |
Why?
| | Interferon-gamma | 1 | 2015 | 784 | 0.020 |
Why?
| | Dendritic Cells | 1 | 2015 | 499 | 0.020 |
Why?
| | T-Lymphocyte Subsets | 1 | 2014 | 415 | 0.020 |
Why?
| | Phenotype | 1 | 2020 | 3172 | 0.020 |
Why?
| | Gene Expression Profiling | 1 | 2018 | 1787 | 0.020 |
Why?
| | Genetic Predisposition to Disease | 1 | 2020 | 2371 | 0.020 |
Why?
| | Granulocytes | 1 | 2011 | 80 | 0.020 |
Why?
| | Epithelial Cells | 1 | 2016 | 1126 | 0.020 |
Why?
| | Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2011 | 161 | 0.020 |
Why?
| | Biodiversity | 1 | 2014 | 426 | 0.020 |
Why?
| | Chi-Square Distribution | 1 | 2011 | 529 | 0.020 |
Why?
| | STAT3 Transcription Factor | 1 | 2011 | 207 | 0.020 |
Why?
| | ROC Curve | 1 | 2011 | 615 | 0.020 |
Why?
| | Down-Regulation | 1 | 2011 | 627 | 0.020 |
Why?
| | Odds Ratio | 1 | 2011 | 1077 | 0.020 |
Why?
| | Cadaver | 2 | 1999 | 307 | 0.020 |
Why?
| | Rest | 1 | 2007 | 124 | 0.020 |
Why?
| | Phosphorylation | 1 | 2011 | 1735 | 0.020 |
Why?
| | Hospital Mortality | 1 | 2011 | 1035 | 0.010 |
Why?
| | Gene Expression Regulation | 1 | 2015 | 2609 | 0.010 |
Why?
| | Logistic Models | 1 | 2011 | 2119 | 0.010 |
Why?
| | Drug Administration Schedule | 1 | 2007 | 783 | 0.010 |
Why?
| | Gastrointestinal Diseases | 1 | 2007 | 216 | 0.010 |
Why?
| | Severity of Illness Index | 1 | 2011 | 2926 | 0.010 |
Why?
| | RNA, Messenger | 1 | 2011 | 2833 | 0.010 |
Why?
| | Body Weight | 1 | 2007 | 980 | 0.010 |
Why?
| | Double-Blind Method | 1 | 2007 | 2033 | 0.010 |
Why?
| | Signal Transduction | 1 | 2015 | 5239 | 0.010 |
Why?
| | Energy Metabolism | 1 | 2007 | 946 | 0.010 |
Why?
| | Evaluation Studies as Topic | 1 | 1999 | 166 | 0.010 |
Why?
| | Bone Wires | 1 | 1999 | 17 | 0.010 |
Why?
| | Weight-Bearing | 1 | 1999 | 181 | 0.010 |
Why?
| | Osteotomy | 1 | 1999 | 127 | 0.010 |
Why?
| | Biomechanical Phenomena | 1 | 1999 | 845 | 0.010 |
Why?
| | Models, Biological | 1 | 1999 | 1823 | 0.010 |
Why?
|
|
Austin's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|